A Study of Ranolazine in ALS

Recruiting

Phase 2

RanolazineA Study of Ranolazine in ALS

Sponsor:

Swathy Chandrashekhar, MD

Code:

NCT06527222

Conditions

Amyotrophic Lateral Sclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ranolazine

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Swathy Chandrashekhar, MD on 2025-04-17.